banner
    RHHBY image

    Roche Holding AG

    RHHBY

    39.14

    USD
    +0.03
    (+0.08%)
    Day's range
    38.88
    39.24
    52 wk Range
    29.2
    44.31

    Key Statistics

    Previous Close
    39.11
    Open
    39.18
    Day's Range
    38.88 - 39.24
    52 wk Range
    29.2 - 44.31
    Volume
    365.98K
    Average Volume
    3.39M
    Market Cap
    253.66B
    Shares Outstanding
    6.48B
    Revenue
    62.40B
    Net Income
    8.28B
    EPS
    1.58
    P/E Value
    24.77
    Next Earnings Date
    Jul 24, 2025
    Dividend (Yield)
    3.73%
    Return on Assets
    10.43%
    Return on Equity
    34.98%
    Gross Profit Margin
    73.61%
    Price/Book
    6.54
    EBITDA
    16.62B
    EV/EBITDA (TTM)
    13.44
    P/BV Value
    6.54
    P/S Value
    3.47
    Beta
    0.216

    Roche Holding AG Company Profile

    Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.

    Industry
    Drug Manufacturers - General
    Sector
    Healthcare
    Employes
    103249
    Market
    CH